Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Answer to February 2019 Photo Quiz.

Tavano C, Pasciuta R, Carletti S, Ossi CM, Ieri R, Cichero P, Clementi N, Burioni R, Clementi M, Mancini N.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e00175-18. doi: 10.1128/JCM.00175-18. Print 2019 Feb. No abstract available.

PMID:
30700561
2.

Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room.

Tavano C, Pasciuta R, Carletti S, Ossi CM, Ieri R, Cichero P, Clementi N, Burioni R, Clementi M, Mancini N.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e00160-18. doi: 10.1128/JCM.00160-18. Print 2019 Feb. No abstract available.

PMID:
30700560
3.

Impact of patients nutritional status on major surgery outcome.

Mignini EV, Scarpellini E, Rinninella E, Lattanzi E, Valeri MV, Clementi N, Abenavoli L, Gasbarrini A, Rasetti C, Santori P.

Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3524-3533. doi: 10.26355/eurrev_201806_15179.

4.

Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle.

Criscuolo E, Clementi N, Mancini N, Burioni R, Miduri M, Castelli M, Clementi M.

Antiviral Res. 2018 Mar;151:71-77. doi: 10.1016/j.antiviral.2018.01.009. Epub 2018 Jan 31.

PMID:
29357297
5.

Atomic mutagenesis of stop codon nucleotides reveals the chemical prerequisites for release factor-mediated peptide release.

Hoernes TP, Clementi N, Juen MA, Shi X, Faserl K, Willi J, Gasser C, Kreutz C, Joseph S, Lindner H, Hüttenhofer A, Erlacher MD.

Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E382-E389. doi: 10.1073/pnas.1714554115. Epub 2018 Jan 3.

6.

Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients.

Mancini N, Greco R, Pasciuta R, Barbanti MC, Pini G, Morrow OB, Morelli M, Vago L, Clementi N, Giglio F, Lupo Stanghellini MT, Forcina A, Infurnari L, Marktel S, Assanelli A, Carrabba M, Bernardi M, Corti C, Burioni R, Peccatori J, Sormani MP, Banfi G, Ciceri F, Clementi M.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx215. doi: 10.1093/ofid/ofx215. eCollection 2017 Fall.

7.

Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge.

Clementi N, Criscuolo E, Cappelletti F, Quaranta P, Pistello M, Diotti RA, Sautto GA, Tarr AW, Mailland F, Concas D, Burioni R, Clementi M, Mancini N.

Antiviral Res. 2017 Jul;143:48-61. doi: 10.1016/j.antiviral.2017.03.028. Epub 2017 Apr 8.

PMID:
28396205
8.

A Biologically-validated HCV E1E2 Heterodimer Structural Model.

Castelli M, Clementi N, Pfaff J, Sautto GA, Diotti RA, Burioni R, Doranz BJ, Dal Peraro M, Clementi M, Mancini N.

Sci Rep. 2017 Mar 16;7(1):214. doi: 10.1038/s41598-017-00320-7.

9.

Role and potential therapeutic use of antibodies against herpetic infections.

Clementi N, Cappelletti F, Criscuolo E, Castelli M, Mancini N, Burioni R, Clementi M.

Clin Microbiol Infect. 2017 Jun;23(6):381-386. doi: 10.1016/j.cmi.2016.12.023. Epub 2017 Jan 3. Review.

10.

Atomic mutagenesis at the ribosomal decoding site.

Schrode P, Huter P, Clementi N, Erlacher M.

RNA Biol. 2017 Jan 2;14(1):104-112. doi: 10.1080/15476286.2016.1256535. Epub 2016 Nov 14.

11.

Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes.

Clementi N, Criscuolo E, Cappelletti F, Burioni R, Clementi M, Mancini N.

Drug Discov Today. 2016 Apr;21(4):682-91. doi: 10.1016/j.drudis.2016.03.003. Epub 2016 Mar 11. Review.

PMID:
26976690
12.

Rational Dosing Strategies of Colistin: What About Resistance?

Mancini N, Clementi N, Burioni R, Clementi M.

Clin Infect Dis. 2016 Apr 15;62(8):1054. doi: 10.1093/cid/ciw019. Epub 2016 Jan 20. No abstract available.

PMID:
26797209
13.

Nucleotide modifications within bacterial messenger RNAs regulate their translation and are able to rewire the genetic code.

Hoernes TP, Clementi N, Faserl K, Glasner H, Breuker K, Lindner H, Hüttenhofer A, Erlacher MD.

Nucleic Acids Res. 2016 Jan 29;44(2):852-62. doi: 10.1093/nar/gkv1182. Epub 2015 Nov 17.

14.

Probing protein orientation near charged nanosurfaces for simulation-assisted biosensor design.

Cooper CD, Clementi NC, Barba LA.

J Chem Phys. 2015 Sep 28;143(12):124709. doi: 10.1063/1.4931113.

PMID:
26429034
15.

Internal-external stimulus competition in a system of interacting moving particles: Persuasion versus propaganda.

Clementi NC, Revelli JA, Sibona GJ.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 Jul;92(1):012816. Epub 2015 Jul 22.

PMID:
26274234
16.

Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?

Mancini N, Sautto GA, Clementi N, Burioni R, Clementi M.

Clin Microbiol Infect. 2015 Aug;21(8):715-6. doi: 10.1016/j.cmi.2015.05.020. Epub 2015 May 28. No abstract available.

17.

Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.

Mancini N, Marrone L, Clementi N, Sautto GA, Clementi M, Burioni R.

Future Microbiol. 2015;10(4):665-82. doi: 10.2217/fmb.14.122. Review.

PMID:
25865200
18.

Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity.

Cappelletti F, Clementi N, Mancini N, Clementi M, Burioni R.

Semin Immunol. 2015 Mar;27(2):138-43. doi: 10.1016/j.smim.2015.03.008. Epub 2015 Apr 6. Review.

PMID:
25857210
19.

The integrity of the G2421-C2395 base pair in the ribosomal E-site is crucial for protein synthesis.

Koch M, Clementi N, Rusca N, Vögele P, Erlacher M, Polacek N.

RNA Biol. 2015;12(1):70-81. doi: 10.1080/15476286.2015.1017218.

20.

Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice.

Retamal M, Abed Y, Rhéaume C, Cappelletti F, Clementi N, Mancini N, Clementi M, Burioni R, Boivin G.

Antimicrob Agents Chemother. 2015 May;59(5):2647-53. doi: 10.1128/AAC.00118-15. Epub 2015 Feb 17.

21.

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

Sautto GA, Wisskirchen K, Clementi N, Castelli M, Diotti RA, Graf J, Clementi M, Burioni R, Protzer U, Mancini N.

Gut. 2016 Mar;65(3):512-23. doi: 10.1136/gutjnl-2014-308316. Epub 2015 Feb 6.

22.

HCV E2 core structures and mAbs: something is still missing.

Castelli M, Clementi N, Sautto GA, Pfaff J, Kahle KM, Barnes T, Doranz BJ, Dal Peraro M, Clementi M, Burioni R, Mancini N.

Drug Discov Today. 2014 Dec;19(12):1964-70. doi: 10.1016/j.drudis.2014.08.011. Epub 2014 Aug 27. Review.

23.

Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.

Diotti RA, Mancini N, Clementi N, Sautto G, Moreno GJ, Criscuolo E, Cappelletti F, Man P, Forest E, Remy L, Giannecchini S, Clementi M, Burioni R.

Antiviral Res. 2014 Aug;108:94-103. doi: 10.1016/j.antiviral.2014.05.017. Epub 2014 Jun 5.

PMID:
24909571
24.

Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis.

Clementi N, Mancini N, Criscuolo E, Cappelletti F, Clementi M, Burioni R.

Methods Mol Biol. 2014;1131:427-46. doi: 10.1007/978-1-62703-992-5_26.

PMID:
24515481
25.

Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures.

Mancini N, Infurnari L, Ghidoli N, Valzano G, Clementi N, Burioni R, Clementi M.

J Clin Microbiol. 2014 Apr;52(4):1242-5. doi: 10.1128/JCM.00142-14. Epub 2014 Jan 29.

26.

JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?

Diotti RA, Nakanishi A, Clementi N, Mancini N, Criscuolo E, Solforosi L, Clementi M.

Clin Dev Immunol. 2013;2013:967581. doi: 10.1155/2013/967581. Epub 2013 Jun 25. Review.

27.

Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides.

Castelli M, Cappelletti F, Diotti RA, Sautto G, Criscuolo E, Dal Peraro M, Clementi N.

Clin Dev Immunol. 2013;2013:521231. doi: 10.1155/2013/521231. Epub 2013 Jun 26. Review.

28.

Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importance.

Mancini N, De Carolis E, Infurnari L, Vella A, Clementi N, Vaccaro L, Ruggeri A, Posteraro B, Burioni R, Clementi M, Sanguinetti M.

J Clin Microbiol. 2013 Jul;51(7):2453-7. doi: 10.1128/JCM.00841-13. Epub 2013 May 15.

29.

Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation.

Dvir R, Mancini N, Assanelli A, Racca S, Rolla S, Clementi N, Piemontese S, Ciceri F, Burioni R, Clementi M.

J Clin Virol. 2013 May;57(1):1-4. doi: 10.1016/j.jcv.2012.11.017. Epub 2012 Dec 17. No abstract available.

PMID:
23253158
30.

Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Clementi N, Criscuolo E, Castelli M, Mancini N, Clementi M, Burioni R.

Viruses. 2012 Nov 14;4(11):3090-108. doi: 10.3390/v4113090. Review.

31.

Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools.

Clementi N, Mancini N, Castelli M, Clementi M, Burioni R.

Drug Discov Today. 2013 May;18(9-10):464-71. doi: 10.1016/j.drudis.2012.11.006. Epub 2012 Nov 21. Review.

PMID:
23178804
32.

Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?

Nicasio M, Sautto G, Clementi N, Diotti RA, Criscuolo E, Castelli M, Solforosi L, Clementi M, Burioni R.

Viruses. 2012 Sep;4(9):1731-52. doi: 10.3390/v4091731. Epub 2012 Sep 24. Review.

33.

Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis.

Clementi N, Criscuolo E, Castelli M, Clementi M.

New Microbiol. 2012 Oct;35(4):399-406. Epub 2012 Oct 1. Review.

34.

Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Clementi N, Mancini N, Solforosi L, Castelli M, Clementi M, Burioni R.

Int J Mol Sci. 2012;13(7):8273-92. doi: 10.3390/ijms13078273. Epub 2012 Jul 4. Review.

35.

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.

Solforosi L, Mancini N, Canducci F, Clementi N, Sautto GA, Diotti RA, Clementi M, Burioni R.

New Microbiol. 2012 Jul;35(3):289-94. Epub 2012 Jun 30.

36.

A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.

De Marco D, Clementi N, Mancini N, Solforosi L, Moreno GJ, Sun X, Tumpey TM, Gubareva LV, Mishin V, Clementi M, Burioni R.

PLoS One. 2012;7(4):e34415. doi: 10.1371/journal.pone.0034415. Epub 2012 Apr 4.

37.

Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images.

Myers JF, Rosso L, Watson BJ, Wilson SJ, Kalk NJ, Clementi N, Brooks DJ, Nutt DJ, Turkheimer FE, Lingford-Hughes AR.

J Cereb Blood Flow Metab. 2012 Apr;32(4):731-44. doi: 10.1038/jcbfm.2011.177. Epub 2012 Jan 4.

38.

A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.

Clementi N, De Marco D, Mancini N, Solforosi L, Moreno GJ, Gubareva LV, Mishin V, Di Pietro A, Vicenzi E, Siccardi AG, Clementi M, Burioni R.

PLoS One. 2011;6(12):e28001. doi: 10.1371/journal.pone.0028001. Epub 2011 Dec 5.

39.

A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.

Mancini N, Solforosi L, Clementi N, De Marco D, Clementi M, Burioni R.

Antiviral Res. 2011 Oct;92(1):15-26. doi: 10.1016/j.antiviral.2011.07.013. Epub 2011 Jul 21. Review.

PMID:
21798290
40.

Ribosome-associated GTPases: the role of RNA for GTPase activation.

Clementi N, Polacek N.

RNA Biol. 2010 Sep-Oct;7(5):521-7. Epub 2010 Sep 1. Review.

PMID:
20657179
41.

Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders.

Fornaro M, Iovieno N, Clementi N, Boscaro M, Paggi F, Balercia G, Fava M, Papakostas GI.

World J Biol Psychiatry. 2010 Dec;11(8):991-6. doi: 10.3109/15622975.2010.491126. Epub 2010 Jun 22.

PMID:
20569197
42.

The role of the universally conserved A2450-C2063 base pair in the ribosomal peptidyl transferase center.

Chirkova A, Erlacher MD, Clementi N, Zywicki M, Aigner M, Polacek N.

Nucleic Acids Res. 2010 Aug;38(14):4844-55. doi: 10.1093/nar/gkq213. Epub 2010 Apr 7.

43.

Atomic mutagenesis reveals A2660 of 23S ribosomal RNA as key to EF-G GTPase activation.

Clementi N, Chirkova A, Puffer B, Micura R, Polacek N.

Nat Chem Biol. 2010 May;6(5):344-51. doi: 10.1038/nchembio.341. Epub 2010 Mar 28.

PMID:
20348921
44.

Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).

Burioni R, Canducci F, Mancini N, Clementi N, Sassi M, De Marco D, Saita D, Diotti RA, Sautto G, Sampaolo M, Clementi M.

New Microbiol. 2009 Oct;32(4):319-24.

45.

Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).

Burioni R, Canducci F, Mancini N, Clementi N, Sassi M, De Marco D, Diotti RA, Saita D, Sampaolo M, Sautto G, Pianezze M, Clementi M.

Virology. 2010 Mar 30;399(1):144-152. doi: 10.1016/j.virol.2009.12.014. Epub 2010 Jan 22.

46.

Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes.

Mancini N, Diotti RA, Perotti M, Sautto G, Clementi N, Nitti G, Patel AH, Ball JK, Clementi M, Burioni R.

PLoS One. 2009 Dec 11;4(12):e8254. doi: 10.1371/journal.pone.0008254.

47.

Medicine and psychiatry in Western culture: Ancient Greek myths and modern prejudices.

Fornaro M, Clementi N, Fornaro P.

Ann Gen Psychiatry. 2009 Oct 7;8:21. doi: 10.1186/1744-859X-8-21.

48.

Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.

Burioni R, Canducci F, Saita D, Perotti M, Mancini N, De Marco D, Clementi N, Chieffo A, Denaro M, Cianflone D, Manfredi AA, Colombo A, Maseri A, Clementi M.

J Immunol. 2009 Aug 15;183(4):2537-44. doi: 10.4049/jimmunol.0901076. Epub 2009 Jul 27.

49.

Medicine and psychiatry in Western culture: among Ancient Greek myths and modern prejudices.

Fornaro M, Clementi N, Fornaro P.

Med Secoli. 2009;21(3):1105-22.

PMID:
21560777
50.

Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.

Burioni R, Mancini N, De Marco D, Clementi N, Perotti M, Nitti G, Sassi M, Canducci F, Shvela K, Bagnarelli P, Mascola JR, Clementi M.

PLoS One. 2008;3(10):e3423. doi: 10.1371/journal.pone.0003423. Epub 2008 Oct 16.

Supplemental Content

Loading ...
Support Center